Lumida
/TBPH
⌘K
Theravance Biopharma Inc

Theravance Biopharma Inc

TBPH
$17.01USD↓-0.06%-0.01 today

MARKET CAP

883.1M

P/E (TTM)

67.0x

FWD P/E

6.6x

DAY RANGE

$17 – $17

52W RANGE

$13
$21

AI Summary

Stalk
Buy NowMedium

TBPH is exhibiting signs of structural repair with a Bullish Pivot Point pattern and price holding above key short-term EMAs. The intermediate trend is supported by mean-reversion dynamics, while the long-term uptrend remains intact. EMAs are flattening and turning higher, and RSI and Options Score show no exhaustion. The momentum-focused strategy favors participation on shallow pullbacks into rising EMA support.

  • ↑Q1 2026 revenue of $17.7M (+15% YoY) driven by YUPELRI partnership
  • ↑ROE at 50% with high earnings yield underscores strong profitability
  • ↓Analysts’ downward revisions highlight weakening earnings outlook
Full analysis →

Buying

7

institutions

Selling

3

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY4.56 M77.56 M+266.20 K+11.2%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY757.96 K12.30 M+357.46 K+64.2%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY537.47 K9.14 M+419.28 K+376.3%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY221.85 K3.78 M+94.58 K+94.9%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY154.32 K2.62 M+26.40 K+26.4%0.00%
MM

Millennium Management LLC

Q2 2026

BUYNEW115.40 K1.96 M+115.40 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY47.82 K812.94 K+20.46 K+83.1%0.00%
MG

Man Group Plc

Q2 2026

SELL40.61 K690.42 K+-1.49 K+1.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL449.007.63 K+-501.00-50.5%0.00%
WP

Woodline Partners LP

Q2 2026

SELL0.000.00+-60.24 K-100.0%0.00%